Cargando…
Explained variation of excess hazard models
The availability of longstanding collection of detailed cancer patient information makes multivariable modelling of cancer‐specific hazard of death appealing. We propose to report variation in survival explained by each variable that constitutes these models. We adapted the ranks explained (RE) meas...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001643/ https://www.ncbi.nlm.nih.gov/pubmed/29633343 http://dx.doi.org/10.1002/sim.7645 |
_version_ | 1783332052464041984 |
---|---|
author | Maringe, Camille Pohar Perme, Maja Stare, Janez Rachet, Bernard |
author_facet | Maringe, Camille Pohar Perme, Maja Stare, Janez Rachet, Bernard |
author_sort | Maringe, Camille |
collection | PubMed |
description | The availability of longstanding collection of detailed cancer patient information makes multivariable modelling of cancer‐specific hazard of death appealing. We propose to report variation in survival explained by each variable that constitutes these models. We adapted the ranks explained (RE) measure to the relative survival data setting, ie, when competing risks of death are accounted for through life tables from the general population. RE is calculated at each event time. We introduce weights for each death reflecting its probability to be a cancer death. RE varies between −1 and +1 and can be reported at given times in the follow‐up and as a time‐varying measure from diagnosis onward. We present an application for patients diagnosed with colon or lung cancer in England. The RE measure shows reasonable properties and is comparable in both relative and cause‐specific settings. One year after diagnosis, RE for the most complex excess hazard models reaches 0.56, 95% CI: 0.54 to 0.58 (0.58 95% CI: 0.56–0.60) and 0.69, 95% CI: 0.68 to 0.70 (0.67, 95% CI: 0.66–0.69) for lung and colon cancer men (women), respectively. Stage at diagnosis accounts for 12.4% (10.8%) of the overall variation in survival among lung cancer patients whereas it carries 61.8% (53.5%) of the survival variation in colon cancer patients. Variables other than performance status for lung cancer (10%) contribute very little to the overall explained variation. The proportion of the variation in survival explained by key prognostic factors is a crucial information toward understanding the mechanisms underpinning cancer survival. The time‐varying RE provides insights into patterns of influence for strong predictors. |
format | Online Article Text |
id | pubmed-6001643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60016432018-06-21 Explained variation of excess hazard models Maringe, Camille Pohar Perme, Maja Stare, Janez Rachet, Bernard Stat Med Research Articles The availability of longstanding collection of detailed cancer patient information makes multivariable modelling of cancer‐specific hazard of death appealing. We propose to report variation in survival explained by each variable that constitutes these models. We adapted the ranks explained (RE) measure to the relative survival data setting, ie, when competing risks of death are accounted for through life tables from the general population. RE is calculated at each event time. We introduce weights for each death reflecting its probability to be a cancer death. RE varies between −1 and +1 and can be reported at given times in the follow‐up and as a time‐varying measure from diagnosis onward. We present an application for patients diagnosed with colon or lung cancer in England. The RE measure shows reasonable properties and is comparable in both relative and cause‐specific settings. One year after diagnosis, RE for the most complex excess hazard models reaches 0.56, 95% CI: 0.54 to 0.58 (0.58 95% CI: 0.56–0.60) and 0.69, 95% CI: 0.68 to 0.70 (0.67, 95% CI: 0.66–0.69) for lung and colon cancer men (women), respectively. Stage at diagnosis accounts for 12.4% (10.8%) of the overall variation in survival among lung cancer patients whereas it carries 61.8% (53.5%) of the survival variation in colon cancer patients. Variables other than performance status for lung cancer (10%) contribute very little to the overall explained variation. The proportion of the variation in survival explained by key prognostic factors is a crucial information toward understanding the mechanisms underpinning cancer survival. The time‐varying RE provides insights into patterns of influence for strong predictors. John Wiley and Sons Inc. 2018-04-06 2018-06-30 /pmc/articles/PMC6001643/ /pubmed/29633343 http://dx.doi.org/10.1002/sim.7645 Text en © 2018 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Maringe, Camille Pohar Perme, Maja Stare, Janez Rachet, Bernard Explained variation of excess hazard models |
title | Explained variation of excess hazard models |
title_full | Explained variation of excess hazard models |
title_fullStr | Explained variation of excess hazard models |
title_full_unstemmed | Explained variation of excess hazard models |
title_short | Explained variation of excess hazard models |
title_sort | explained variation of excess hazard models |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001643/ https://www.ncbi.nlm.nih.gov/pubmed/29633343 http://dx.doi.org/10.1002/sim.7645 |
work_keys_str_mv | AT maringecamille explainedvariationofexcesshazardmodels AT poharpermemaja explainedvariationofexcesshazardmodels AT starejanez explainedvariationofexcesshazardmodels AT rachetbernard explainedvariationofexcesshazardmodels |